Peder Olofsson

Feinstein eyes bioelectronic BP breakthrough

A new study by the head of the Feinstein Institute for Medical Research may open the door to bioelectronic treatments for hypertension and high blood pressure. In a study published this month by the prestigious peer-reviewed scientific journal Nature Biotechnology, researchers from the Feinstein Institute – the R&D arm of the Northwell Health system – and the Karolinska Institutet, Sweden’s top medical university, discuss findings regarding T-cells and their ability to produce neurotransmitters that can…